WIRE — AstraZeneca Pharma India received approval from the CDSCO to import and sell Enhertu for an additional HER2 positive breast cancer indication in India.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.